Anbio Biotechnology (NNNN) Other Accumulated Expenses (2023 - 2025)

Anbio Biotechnology has reported Other Accumulated Expenses over the past 3 years, most recently at $87836.0 for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $87836.0 for Q4 2025, down 16.33% from a year ago — trailing twelve months through Dec 2025 was $87836.0 (down 16.33% YoY), and the annual figure for FY2025 was $87836.0, down 16.33%.
  • Other Accumulated Expenses for Q4 2025 was $87836.0 at Anbio Biotechnology, down from $104979.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for NNNN hit a ceiling of $165909.0 in Q4 2023 and a floor of $87836.0 in Q4 2025.
  • Median Other Accumulated Expenses over the past 3 years was $104979.0 (2024), compared with a mean of $119574.7.
  • Biggest five-year swings in Other Accumulated Expenses: crashed 36.72% in 2024 and later dropped 16.33% in 2025.
  • Anbio Biotechnology's Other Accumulated Expenses stood at $165909.0 in 2023, then crashed by 36.72% to $104979.0 in 2024, then decreased by 16.33% to $87836.0 in 2025.
  • The last three reported values for Other Accumulated Expenses were $87836.0 (Q4 2025), $104979.0 (Q4 2024), and $165909.0 (Q4 2023) per Business Quant data.